Publications by authors named "Hany Ibrahim Ragy"
Introduction: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) aims to determine real-life treatment patterns and clinical outcomes of patients with newly diagnosed non-valvular atrial fibrillation (AF) and at least one investigator-determined risk factor for stroke. The registry includes a wide array of baseline characteristics and has a particular focus on: (1) bleeding and thromboembolic events; (2) international normalized ratio fluctuations; and (3) therapy compliance and persistence patterns.
Methods: Evolution in baseline treatment for patients enrolled in sequential cohorts showed an increase in prescribing of novel oral anticoagulants over time.
Article Synopsis
- The GARFIELD-AF registry aimed to track treatment practices for newly diagnosed atrial fibrillation patients, focusing on the shift from vitamin K antagonists (VKAs) to non-vitamin K antagonist oral anticoagulants (NOACs).
- Data from over 24,000 patients revealed that factors like country, care setting, type of atrial fibrillation, and kidney health significantly influenced the choice between NOACs and VKAs.
- Results showed a trend towards prescribing NOACs for lower-risk and certain elderly patients, while VKAs were more common for those with higher risk conditions such as permanent atrial fibrillation or serious kidney issues.